학술논문
Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature
Document Type
Review Article
Author
Source
In ESMO Open August 2021 6(4)
Subject
Language
ISSN
2059-7029